Clinical Trials Related to EB in Australia
The following clinical trials in EB are currently active in Australia. Anyone who is interested in participating or learning more about a trial is encouraged to contact the relevant study centre to obtain further information.
DEBRA Australia does not endorse any trial participation, and members should discuss involvement with their treating physician.
| Trial | Status | Links for More Information |
|---|---|---|
| COSEB Study
Core Outcome Sets for Epidermolysis Bullosa, Principal Investigator: Amy Paller, Lurie Children’s Hospital, Chicago. |
Recruiting | For further details on the study and participant requirements: COSEB Study Flyer (PDF) |
| EBShield Study
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS) |
Active. Not recruiting. | EBShield Study – further information
ANZCTR – Registration View more info about EBS and Premier Specialists Dermatology View Clinical Trial flyer – Premier Specialist |
| Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa (EASE) | Study Closed | https://clinicaltrials.govStudy identifier NCT03068780 |
| Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study | Study Closed | https://clinicaltrials.govStudy identifier NCT03016715 |
| An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS) | Study Closed | https://clinicaltrials.govStudy identifier: NCT03154333
Study Language for Patient Advocacy Website: http://www.deliversebs.com |